Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1979-01-01 (47 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: BELFORT (90000), Territoire de Belfort
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DES VOSGES : revenue, balance sheet and financial ratios
PHARMACIE DES VOSGES is a French company
founded 47 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in BELFORT (90000),
this company of category PME
shows in 2021 a net income positive of 46 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DES VOSGES (SIREN 314979378)
Indicator
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
46 442 €
71 027 €
87 836 €
97 803 €
78 030 €
118 783 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2021, PHARMACIE DES VOSGES generates positive net income of 46 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2021: 119 k€ -> 46 k€.
Net income (2021)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
46 442 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 281%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2021)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
280.87%
Financial autonomy (2021)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
14.654%
Asset age ratio (2021)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DES VOSGES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
Debt ratio
129.666
170.642
108.013
123.92
200.83
280.87
Financial autonomy
29.924
23.529
26.61
26.205
20.863
14.654
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
280.872021
2019
2020
2021
Q1: 29.04
Med: 85.54
Q3: 208.43
Average+21 pts over 3 years
In 2021, the debt ratio of PHARMACIE DES VOSGES (280.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
14.65%2021
2019
2020
2021
Q1: 25.89%
Med: 44.41%
Q3: 64.18%
Watch
In 2021, the financial autonomy of PHARMACIE DES VOSGES (14.7%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 130.68. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2021)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
130.68
Liquidity indicators evolution PHARMACIE DES VOSGES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
Liquidity ratio
222.662
137.392
113.992
93.574
150.43
130.68
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
130.682021
2019
2020
2021
Q1: 139.2
Med: 190.68
Q3: 259.61
Watch
In 2021, the liquidity ratio of PHARMACIE DES VOSGES (130.68) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE DES VOSGES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2021,
the value of PHARMACIE DES VOSGES is estimated at
532 709 €
(range 342 534€ - 822 868€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2021
220 transactions
342k€532k€822k€
532 709 €Range: 342 534€ - 822 868€
NAF 5 année 2021
Valuation method used
Net Income Multiple
46 442 €
×
11.5x
=532 709 €
Range: 342 535€ - 822 868€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DES VOSGES with other companies in the same sector:
Frequently asked questions about PHARMACIE DES VOSGES
What is the revenue of PHARMACIE DES VOSGES ?
The revenue of PHARMACIE DES VOSGES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DES VOSGES profitable?
Yes, PHARMACIE DES VOSGES generated a net profit of 46 k€ in 2021.
Where is the headquarters of PHARMACIE DES VOSGES ?
The headquarters of PHARMACIE DES VOSGES is located in BELFORT (90000), in the department Territoire de Belfort.
Where to find the tax return of PHARMACIE DES VOSGES ?
The tax return of PHARMACIE DES VOSGES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DES VOSGES operate?
PHARMACIE DES VOSGES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart